Previous Close | 66.86 |
1-Year Change | 5.14% |
6-Months Change | -18.96% |
3-Months Change | -7.58% |
Moving Avg (50d) | 74.122 |
Moving Avg (200d) | 73.616 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 10.6B |
Beta (3-Years) | 1.15 |
Revenue Growth (ttm) | 2.37% |
Net Profit Margin (ttm) | 21.57% |
Return On Assets (ttm) | 8.95% |
EPS (ttm) | 1.51 |
PE Ratio (ttm) | 44.28 |
Dividend Yield | 0.72% |
Asset Description: | Bio-Techne Corporation |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
77.54 | 79.821 | 81.341 | 83.622 | 87.423 | 91.224 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia